Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

17α-estradiol extends lifespan and improves metabolism in male mice through the estrogen receptor α.

Prescription tablets treat hirsutism, while over-the-counter foams treat hypertrichosis.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Equol may help with antiaging and skin health by boosting collagen and blocking certain hormones.

A new method effectively predicts estrogen-related health effects for early screening.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Strontium ranelate is no longer available for treatment.

Spironolactone effectively treats hormonal acne, hair loss, and excess hair growth in women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Certain medications can negatively impact male fertility.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.